Skip to main content
. Author manuscript; available in PMC: 2023 Oct 2.
Published in final edited form as: Ophthalmic Physiol Opt. 2020 Oct 29;41(1):21–32. doi: 10.1111/opo.12747

TABLE 5.

Proportion of participants reaching normal accommodative amplitude or facility by treatment group at each time point

Vergence/Accommodative
% (95% CI)
Placebo
% (95% CI)
Time Point Normal Accommodative Amplitude
Week 4 47% (37% to 56%) 19% (10% to 30%)
Week 8 58% (49% to 68%) 23% (13% to 35%)
Week 12 63% (53% to 72%) 35% (24% to 48%)
Week 16 69% (59% to 77%) 32% (21% to 45%)
Time Point Normal Accommodative Facility
Week 4 36% (25% to 49%) 14% (5% to 29%)
Week 8 68% (56% to 79%) 39% (23% to 57%)
Week 12 87% (77% to 94%) 35% (20% to 53%)
Week 16 85% (74% to 93%) 49% (32% to 66%)

Normal accommodative amplitude defined as amplitude ≥ 14 diopters.

Normal accommodative facility defined as facility ≥ 11 cycles per minute.

95% CI = confidence interval.